Trem2 enhances the phagocytosis function of microglia and suppress neuroinflammation; in humans, TREM2 loss-of-function variants are associated with Alzheimer’s disease (65, 87). Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.